These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1183243)

  • 1. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and clinical studies of 5-fluorocytosine activity in candida ocular infections, II. The effect of 5-fluorocytosine in treating experimental candida infection in rabbits' eyes.
    Segal E; Romano A; Eylan E; Stein R
    Infection; 1975; 3(3):165-8. PubMed ID: 1223007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
    Sakellarides E
    Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of external ocular Candida infections with 5-fluorocytosine.
    Romano A; Segal E; Eylan E; Stein R
    Ophthalmologica; 1976; 172(4):282-6. PubMed ID: 765917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.
    Shadomy S; Kirchoff CB; Ingroff AE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):9-14. PubMed ID: 4799552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity.
    Edwards JE; Montgomerie JZ; Ishida K; Morrison JO; Guze LB
    J Infect Dis; 1977 Feb; 135(2):294-7. PubMed ID: 320277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The resistance behavior of yeast isolates from defined patient groups to 5-fluorocytosine].
    Weber S; Polak-Wyss A
    Mycoses; 1991; 34 Suppl 1():77-81. PubMed ID: 1818269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
    Schönebeck J; Anséhn S
    Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
    Auger P; Dumas C; Joly J
    J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of yeast isolates from defined German patient groups to 5-fluorocytosine.
    Weber S; Polak A
    Mycoses; 1992; 35(7-8):163-71. PubMed ID: 1287480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
    Zer Y; Balci I; Meriç G
    New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimycotic activity of 5-fluorocytosine.
    Holt RJ; Newman RL
    J Clin Pathol; 1973 Mar; 26(3):167-74. PubMed ID: 4700499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbits.
    Demierre G; Freedman LR
    Antimicrob Agents Chemother; 1979 Sep; 16(3):252-4. PubMed ID: 389156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.